Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henrik Vestergaard

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 23, 2008
Insulinoma in a third-trimester pregnant woman combined with pre-eclampsia: a case report and review of the diagnostic strategiesErik Christiansen, Henrik Vestergaard
Molecular Genetics and Metabolism|September 21, 2014
The potential role of inhibitor of differentiation-3 in human adipose tissue remodeling and metabolic healthMathilde Svendstrup, Henrik Vestergaard
World Journal of Surgery|June 8, 2002
Normocalcemia and persistent elevated serum concentrations of 1-84 parathyroid hormone after operation for sporadic parathyroid adenoma: evidence of increased morbidity from cardiovascular diseaseHenrik Vestergaard, Lars ØStergaard Kristensen
Cardiovascular Diabetology|November 26, 2009
YKL-40--an emerging biomarker in cardiovascular disease and diabetesCamilla N Rathcke, Henrik Vestergaard
Clinical Endocrinology|August 31, 2007
Concentrations of the acute phase reactants high-sensitive C-reactive protein and YKL-40 and of interleukin-6 before and after treatment in patients with acromegaly and growth hormone deficiencyMikkel Andreassen, Henrik Vestergaard, Lars Østergaard Kristensen
Cardiovascular Diabetology|June 24, 2011
YKL-40 levels are independently associated with albuminuria in type 2 diabetesAnne K Røndbjerg, Emina Omerovic, Henrik Vestergaard
Ugeskrift for Laeger|January 22, 2010
[Polycystic ovary syndrome and comorbidity]Line Klingen Haugaard, Henrik Vestergaard, Sven Olaf Skouby
Archives of Microbiology|May 8, 2016
Aerobic and anaerobic cellulase production by Cellulomonas udaHenrik Vestergaard Poulsen, Fillip Wolfgang Willink, Kjeld Ingvorsen
BMJ Open|March 19, 2018
Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates: a retrospective cohort study from a specialised diabetes centre in DenmarkNarges Safai, Bendix Carstensen, Henrik Vestergaard, et al.
Archives of Internal Medicine|July 14, 2004
The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-upThomas Almdal, Henrik Scharling, Jan Skov Jensen, et al.
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 23, 2008
Insulinoma in a third-trimester pregnant woman combined with pre-eclampsia: a case report and review of the diagnostic strategiesErik Christiansen, Henrik Vestergaard
Molecular Genetics and Metabolism|September 21, 2014
The potential role of inhibitor of differentiation-3 in human adipose tissue remodeling and metabolic healthMathilde Svendstrup, Henrik Vestergaard
World Journal of Surgery|June 8, 2002
Normocalcemia and persistent elevated serum concentrations of 1-84 parathyroid hormone after operation for sporadic parathyroid adenoma: evidence of increased morbidity from cardiovascular diseaseHenrik Vestergaard, Lars ØStergaard Kristensen
Cardiovascular Diabetology|November 26, 2009
YKL-40--an emerging biomarker in cardiovascular disease and diabetesCamilla N Rathcke, Henrik Vestergaard
Clinical Endocrinology|August 31, 2007
Concentrations of the acute phase reactants high-sensitive C-reactive protein and YKL-40 and of interleukin-6 before and after treatment in patients with acromegaly and growth hormone deficiencyMikkel Andreassen, Henrik Vestergaard, Lars Østergaard Kristensen
Cardiovascular Diabetology|June 24, 2011
YKL-40 levels are independently associated with albuminuria in type 2 diabetesAnne K Røndbjerg, Emina Omerovic, Henrik Vestergaard
Ugeskrift for Laeger|January 22, 2010
[Polycystic ovary syndrome and comorbidity]Line Klingen Haugaard, Henrik Vestergaard, Sven Olaf Skouby
Archives of Microbiology|May 8, 2016
Aerobic and anaerobic cellulase production by Cellulomonas udaHenrik Vestergaard Poulsen, Fillip Wolfgang Willink, Kjeld Ingvorsen
BMJ Open|March 19, 2018
Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates: a retrospective cohort study from a specialised diabetes centre in DenmarkNarges Safai, Bendix Carstensen, Henrik Vestergaard, et al.
Archives of Internal Medicine|July 14, 2004
The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-upThomas Almdal, Henrik Scharling, Jan Skov Jensen, et al.
Pageof 14